1.15
1.15 (0%)
As of Feb 14, 2025
Actinium Pharmaceuticals, Inc. [ATNM]
Source:
Company Overview
Actinium Pharmaceuticals, Inc. is a pioneer in the development of targeted radiotherapiesintended to meaningfully improve outcomes for patients with advanced cancers including relapsed or refractory (“r/r”) diseasewho have failed existing therapies.
Country | United States |
Headquarters | new york, new york |
Phone Number | (646) 677-3870 |
Industry | manufacturing |
CEO | Sandesh Seth |
Website | actiniumpharma.com |